Opendoor: Upcoming Earnings a Critical Test as Zacks Flags Negative Trend

What happened

A Zacks Investment Research article published April 30, 2026, warns that Opendoor Technologies (OPEN) lacks the key ingredients for an earnings beat in its upcoming report, echoing the thesis of the latest DeepValue master report. DeepValue’s analysis rates OPEN as a “WAIT” with a base-case fair value of $6.50, emphasizing that the next two quarters must confirm the acquisition ramp does not rebuild aging inventory or erode contribution margins. Zacks’ negative outlook before the release reinforces the report’s concern that consensus estimates may be too optimistic given the company’s fragile operating model and balance-sheet sensitivity. The article does not introduce new information but aligns with DeepValue’s assessment that execution proof points, particularly on >120-day inventory and contribution margins, are needed before a more constructive stance is warranted. Thus, the stock remains a high-volatility catalyst-driven trade until the earnings report provides concrete evidence of sustainable progress.

Implication

The Zacks article validates DeepValue’s “WAIT” rating, as OPEN remains tied to fragile housing-market dynamics and funding capacity. For long-term investors, entry points near DeepValue’s attractive entry of $4.25 are preferable, but only if the next earnings report shows >120-day inventory at or below 35% and contribution margin above 3.4%. Without these proof points, the downside scenario of $3.50 becomes more likely, especially if mortgage rates stay elevated and put pressure on resale clearance. A buy thesis only emerges if the operational ramp is confirmed without rebuilding the historical failure mode of markdowns and inventory aging.

Thesis delta

The Zacks article reinforces caution but does not alter DeepValue’s fundamental view. The key near-term catalyst is the upcoming earnings release, which will either confirm the operational turnaround or expose renewed weakness. Until then, the WAIT rating and target entry at $4.25 remain appropriate, with the stock trading near $5.20 offering no margin of safety.